Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Return on Capital %

Apellis Pharmaceuticals Inc Return on Capital % Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Return on Capital % from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Return on Capital % for the quarter ending September 09, 2018 was -37.36 a -28.40% increase of 10.61 year over year
  • Apellis Pharmaceuticals Inc Return on Capital % for the last 12 months ending September 09, 2018 was -57.81 a 44.88% decrease of -25.95 year over year
  • Apellis Pharmaceuticals Inc Annual Return on Capital % for 2017 was -31.87 a -82.08% increase of 26.16 from 2016
  • Apellis Pharmaceuticals Inc Annual Return on Capital % for 2016 was -58.03 a 10.23% decrease of -5.94 from 2015
  • Apellis Pharmaceuticals Inc Annual Return on Capital % for 2015 was -52.09
Other Margins & Efficiency Metrics:
  • Apellis Pharmaceuticals Inc Return on Equity % for the quarter ending September 09, 2018 was -67.63 a -34.01% increase of 23.00 year over year
View Chart On Koyfin

Quarterly APLS Return on Capital % Data

09/2018-37.36
06/2018-40.64
03/2018-32.38
12/2017-47.97
09/2017-373.14
06/2017-223.68

Annual APLS Return on Capital % Data

2017-31.87
2016-58.03
2015-52.09